Aging related erectile dysfunction-potential mechanism to halt or delay its onset

Area of Science:

• Urology
• Gerontology
• Vascular Biology

Background:

• Erectile dysfunction (ED) prevalence increases with age, affecting a significant portion of men.
• The primary cause of ED, irrespective of age, is vascular dysfunction, specifically the loss of corporal smooth muscle cells (SMC).
• This SMC degradation leads to impaired blood retention in the penis, a condition exacerbated by aging.

Purpose of the Study:

• To investigate the cellular mechanisms underlying age-related erectile dysfunction.
• To explore the role of inducible nitric oxide synthase (iNOS) in combating oxidative stress and SMC apoptosis.
• To determine if pharmacological upregulation of the iNOS pathway can reverse ED-related vascular changes.

Main Methods:

• Analysis of corporal smooth muscle cell (SMC) function and loss in aging.
• Investigation of inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production in response to oxidative stress.
• Pharmacological upregulation of the iNOS pathway to assess its impact on corporal tissue and venous leakage.

Main Results:

• Aging leads to the degradation and loss of corporal smooth muscle cells (SMC), impacting penile vascular function.
• SMC attempt to counteract aging-induced oxidative stress and apoptosis by expressing iNOS and producing nitric oxide (NO).
• Pharmacological upregulation of the iNOS pathway resulted in the reversal of age-related vascular changes and corrected venous leakage.

Conclusions:

• Age-related ED is primarily caused by the loss of corporal smooth muscle cells (SMC) and subsequent vascular dysfunction.
• The iNOS/NO pathway plays a crucial role in protecting SMC from oxidative stress and apoptosis.
• Targeting the iNOS pathway offers a promising therapeutic strategy for reversing age-related ED and potentially treating essential hypertension.